SuperworthPro DEX EPS PDEX
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $4.11
- Latest quarter, Q4 FY26
- $0.85
- +136% on a year earlier
- Fiscal year 2026
- $4.11
- +52% on the year before
Pro DEX's earnings per share was $4.11 over the twelve months to Jun 30, 2026, up 52% on a year earlier.
In its latest quarter, Q4 FY26, it was $0.85, up 136% on the same quarter a year before.
Over the five fiscal years to FY2026 it grew 21% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | $4.11 | +52% |
| FY2025 | $2.70 | +335% |
| FY2024 | $0.62 | −68% |
| FY2023 | $1.95 | +61% |
| FY2022 | $1.21 | −23% |
| FY2021 | $1.57 | +5% |
| FY2020 | $1.50 | +55% |
| FY2019 | $0.97 | +155% |
| FY2018 | $0.38 | −70% |
| FY2017 | $1.25 | +525% |
| FY2016 | $0.20 | n/a |
| FY2015 | −$0.09 | n/a |
| FY2014 | −$0.15 | n/a |
| FY2013 | −$0.54 | n/a |
| FY2012 | −$0.27 | −134% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q4 FY26 | $0.85 | +136% | $4.11 | |
| Q3 FY26 | $1.20 | +22% | $3.62 | |
| Q2 FY26 | $0.66 | +8% | $3.40 | |
| Q1 FY26 | $1.40 | +87% | $3.35 | |
| Q4 FY25 | $0.36 | −22% | $2.70 | |
| Q3 FY25 | $0.98 | +416% | $2.80 | |
| Q2 FY25 | $0.61 | +336% | $2.01 | |
| Q1 FY25 | $0.75 | n/a | $1.54 | |
| Q4 FY24 | $0.46 | +10% | $0.62 | |
| Q3 FY24 | $0.19 | −58% | $0.58 | |
| Q2 FY24 | $0.14 | −81% | $0.84 | |
| Q1 FY24 | −$0.17 | −152% | $1.45 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Pro DEX's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| PDEXPro DEX | $4.11 | +52% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| MOVMovado | $1.80 | +137% a year |
| NEPHNephros | $0.16 | +33% a year |
| IRMDIradimed | $1.79 | +10% a year |
| Peer median | $1.27 |
Where Pro DEX ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Pro DEX
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.